LITTLE FALLS, N.J.,
March 25, 2013 /PRNewswire/
-- CANTEL MEDICAL CORP. (NYSE: CMN), through its Mar
Cor Purification subsidiary, has continued the expansion of its
water purification and filtration unit with the purchase of the
hemodialysis water business from Siemens' Water Technologies
business unit. With approximately 600 dialysis customers in
the United States and Canada and 2012 revenue of approximately
$9 million, this acquisition
significantly expands Mar Cor Purification's North American
footprint. The acquisition is expected to be slightly accretive to
Cantel Medical's earnings per share in fiscal year 2013 and
beyond.
Curtis Weitnauer, President and
CEO of Mar Cor Purification, stated, "The acquisition of the
Siemens hemodialysis water customer base enables Mar Cor to realize
increased efficiencies from our existing field service operations
while also expanding our footprint into new geographies. With
this geographic expansion, Mar Cor will further improve its ability
to service its large national customers. We look forward to
continuing to provide our unique dialysis products and services to
our new and existing customers."
Cantel Medical's President and CEO, Andrew Krakauer, added, "This acquisition
strengthens our position as a leading provider of water
purification products and services to the dialysis industry.
Our advanced heat-based disinfection water technology coupled with
our nationwide service footprint makes Mar Cor the best choice for
infection prevention and control to our dialysis
customers. We remain confident that our water
purification and filtration segment will continue to demonstrate
industry leading performance."
About Mar Cor Purification, Inc.
A subsidiary of Cantel Medical Corp., Mar Cor Purification is
dedicated to providing innovative solutions through filtration,
water purification, and disinfection technologies to the medical,
life science and industrial marketplaces. Mar Cor Purification has
service offices in 22 cities in the U.S. and Canada, with 7 resin regeneration plants
strategically located in Atlanta,
Boston, Chicago, Philadelphia, San
Antonio, Montreal and
Toronto. For more information
please visit http://www.mcpur.com.
About Cantel Medical Corp.
Cantel Medical Corp. (NYSE:CMN) is a leading provider of
infection prevention and control products in the healthcare market.
Our products include water purification equipment, sterilants,
disinfectants and cleaners, specialized medical device reprocessing
systems for endoscopy and renal dialysis, disposable infection
control products primarily for dental and GI endoscopy markets,
dialysate concentrates and other dialysis supplies, hollow fiber
membrane filtration and separation products for medical and
non-medical applications, and specialty packaging for infectious
and biological specimens. We also provide technical maintenance for
our products and offer compliance training services for the
transport of infectious and biological specimens.
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. These statements involve a number of risks and uncertainties,
including, without limitation, the risks detailed in Cantel's
filings and reports with the Securities and Exchange Commission.
Such forward-looking statements are only predictions, and actual
events or results may differ materially from those projected or
anticipated.
SOURCE Cantel Medical Corp.